Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis.
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
Anne-Fleur Louise
AL
Van der Paardt
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.|University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Onno W
OW
Akkerman
Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" - IRCCS, Rome, Italy.
Gina
G
Gualano
Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" - IRCCS, Rome, Italy.
Fabrizio
F
Palmieri
Unit of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.|Dept of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
Lina
L
Davies Forsman
Educational Institution "Grodno State Medical University", Grodno, Belarus.
Alena
A
Aleksa
Division of Infection, Barts Health NHS Trust, London, UK.
Simon
S
Tiberi
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.|University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Wiel C M
WC
de Lange
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
Mathieu S
MS
Bolhuis
Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
Alena
A
Skrahina
National Mycobacteria Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.|Depts of Pulmonary Diseases and Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Dick
D
van Soolingen
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.|University of Groningen, Dept of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, Groningen, The Netherlands.
Jos G W
JG
Kosterink
WHO Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS, Tradate, Italy.
Giovanni Battista
0000-0002-2597-574X
GB
Migliori
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.|University of Groningen, University Medical Center Groningen, Dept of Internal Medicine - Infectious Diseases, Groningen, The Netherlands.
Tjip S
TS
van der Werf
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands j.w.c.alffenaar@umcg.nl.
Jan-Willem C
JC
Alffenaar
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017291:Clarithromycin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D012008:Recurrence; D013183:Sputum / Q000382:microbiology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
D000995:Antitubercular Agents; D017291:Clarithromycin